# A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence

> **NCT06845124** · PHASE2 · RECRUITING · sponsor: **Central Institute of Mental Health, Mannheim** · enrollment: 150 (estimated)

## Conditions studied

- Alcohol Addiction
- Alcoholism

## Interventions

- **DRUG:** Cannabidiol capsules
- **DRUG:** Naltrexone (drug)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06845124
- **Lead sponsor:** Central Institute of Mental Health, Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-22
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-09-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06845124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06845124, "A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06845124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*